Cite
APA Citation
Bicakli, D. H., Varol, U., Degirmenci, M., Tunali, D., Cakar, B., Durusoy, R., Karaca, B., Sanli, U. A., & Uslu, R. (n.d.). reply To the Editor, Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315. Journal of oncology pharmacy practice, 21, 318–319. http://access.bl.uk/ark:/81055/vdc_100066040446.0x00002a